5[5]Ambiru S,Miyazaki M.Effect of perioperative ptotease inhibitor on inflammatory cytokines and acute-phase protients with hepotic resection[J].Dig Surg,2000,Vol.17:337-343.
6[6]Bone R.Immunology dissonance:a continuing evolution in our understanding of the systemic Inflammatory respons syndrome[J].Ann Int Med,1996,125:680-687.
2Bone R. Immunology dissonance: a continuing evolution in our understanding of the systemic Inflammatory response syndromes and the multiple organ dysfunction syndrome. Ann Int Med,1996, 125: 680-687.
3Kahama H, Kuribayashi K, Susita M, et al. Cytoprotective effect of ulinastatin, a kunitztype protease inhibitor, on hypoxic injury in L-2 cells treated with antimycin A via stabilization of lysosomal fragility. Pulm Pharmacol Ther. 1999, 12: 1-6.
4Kawamura T, Inada K, Akasaka N, Wakusawa R. Ulinastain reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth. 1996, 43: 456-460.
5Ambiru S, Miyazaki M. Effects of perioperative protease inhibitor on inflammatory cytokines and acute-phase proteins in patients with hepotic resection. Dig Sury. 2000, Vol. 17: 337-343.
6Bed AL, Lerra FB. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA,1994, 271: 226-233.
7Kobayashi H,Shinohara H,Gotoh J,et al.Anti-metastasis therapy by urinary tyrpsin inhibitor in combination with an anti-cancer agent[].British Journal of Cancer.1995
8Hiyama A,Takeda J,Kotake Y,et al.A human urinary protease inhibitor (ulinastatin) inhibits neurrophil extracellular release of elastase during cardiopulmonary bypasss[].Journal of Cardiothoracic and Vascular Anesthesia.1997
9Kobayashi H,Shinohara H,Fujie M,et al.Inbibition of metastasis of lewis lung carcinoma by urinary trapsin inhibitor in experimental and spontaneous metastasis models[].International Journal of Cancer.1995
7Pugia MJ, Valdes RJ, Jortani SA. Bikunin (urinary trypsin inhibitor) :Structure, biological relevance, and measurement[J]. Adv CAin Chem, 2007,44 : 223-245.
8Umeadi C, Kandeel F, Al-Abdullah IH. Ulinastatin is a novd protease inhibitor and neutral protease activator[J]. Transplant Proc, 2008,40(2) :387-389.
9Molor-Erdene P, Okajima K, Isobe H, et al, Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo[J]. Thromb Haemost, 2005,94 (1) :136-145.
10Park KH,Lee KH,Kim H,et al.The anti-inflammatory effects of ulinastatin in trauma patients with hemorrhagic shock[J].J Korean Med Sci,2010,25(1):128-134.
